Identification of Noncompetitive Protein-Ligand Interactions for Structural Optimization.
Andreas Tosstorff1,2, Jason C Cole2, Robin Taylor2
1Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.
This study introduces an enhanced statistical ratio of frequencies (RF) method to identify poor protein-ligand interactions in drug design. This approach helps focus medicinal chemistry efforts on optimizing molecular recognition for better drug candidates.
Area of Science:
- Computational chemistry
- Structural biology
- Medicinal chemistry
Background:
- Understanding protein-ligand interactions is crucial for structure-guided drug design.
- Identifying suboptimal molecular contacts can direct optimization efforts.
- Existing methods may not efficiently highlight poor interactions.
Purpose of the Study:
- To present an enhanced statistical ratio of frequencies (RF) approach for identifying poor protein-ligand interactions.
- To provide a comprehensive overview of noncompetitive interactions and geometries for common ligand substituents.
- To demonstrate the utility of this method in drug design through case studies.
Main Methods:
- Utilized an enhanced version of the statistical ratio of frequencies (RF) method.
- Analyzed protein-ligand interactions and geometries against the Protein Data Bank.
- Performed retrospective case studies on pharmaceutical targets with congeneric series and mutations.
Main Results:
- The enhanced RF approach effectively highlights protein-ligand interactions and geometries that are statistically infrequent.
- A comprehensive overview of noncompetitive interactions for common ligand substituents was generated.
- Case studies demonstrated the practical application of identifying and addressing poor interactions in drug design.
Conclusions:
- The enhanced RF method provides a straightforward way to identify and characterize suboptimal protein-ligand contacts.
- This knowledge can be strategically exploited to improve molecular recognition and guide drug design efforts.
- The approach facilitates focused optimization of ligand regions for enhanced binding affinity and efficacy.
More Related Videos
07:33Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
Published on: October 15, 2018
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Protein-protein Interfaces
Protein-Protein Interfaces
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Ligand Binding and Linkage
